The pharmaceutical company tested their optimized baby formula on the poorest populations. Nine years later, their data was stunning. The babies fattened on that patented elixir were phenomenally robust, stunningly brilliant, taller and more athletic than the experimental controls. But twenty years later, the results were less compelling. No matter how impressive the formula-fed children were in regards to cerebral ability or physicality, the social and economic standing of their parents determined their adult outcomes exponentially more. Brilliant, sturdy children of the poor fared far worse than dull, weak offspring of the wealthy. Breast remained obviously best, if only as a brand.